MoonLake Immunotherapeutics
MLTX
MLTX
23 hedge funds and large institutions have $190M invested in MoonLake Immunotherapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
15% less funds holding
Funds holding: 27 → 23 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$114M | |
| 2 | +$14.2M | |
| 3 | +$10.3M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$5.25M |
| 5 |
RI
RTW Investments
New York
|
+$2.63M |
Top Sellers
| 1 | -$7.9M | |
| 2 | -$7.26M | |
| 3 | -$6.35M | |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$5.1M |
| 5 |
AWG
Alpha Wave Global
New York
|
-$4.49M |